Growing community of inventors

New Brunswick, NJ, United States of America

Yongmei Wu

Average Co-Inventor Count = 8.00

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 64

Yongmei Wu ↔ Prakash V Parab (5 patents)Yongmei Wu ↔ Mandar V Dali (5 patents)Yongmei Wu ↔ Ravindra W Tejwani (5 patents)Yongmei Wu ↔ Jatin M Patel (5 patents)Yongmei Wu ↔ Dilbir S Bindra (5 patents)Yongmei Wu ↔ Li Tao (5 patents)Yongmei Wu ↔ Nipa Vatsaraj (5 patents)Yongmei WuYongmei Wu (5 patents)Prakash V ParabPrakash V Parab (18 patents)Mandar V DaliMandar V Dali (14 patents)Ravindra W TejwaniRavindra W Tejwani (11 patents)Jatin M PatelJatin M Patel (10 patents)Dilbir S BindraDilbir S Bindra (7 patents)Li TaoLi Tao (5 patents)Nipa VatsarajNipa Vatsaraj (5 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bristol-myers Squibb Compnay (4 from 3,681 patents)

2. Astrazeneca Ab (1 from 1,500 patents)


5 patents:

1. 9198925 - Pharmaceutical formulations containing an SGLT2 inhibitor

2. 8716251 - Pharmaceutical formulations containing an SGLT2 inhibitor

3. 8361972 - Pharmaceutical formulations containing an SGLT2 inhibitor

4. 8221786 - Pharmaceutical formulations containing an SGLT2 inhibitor

5. 7851502 - Pharmaceutical formulations containing an SGLT2 inhibitor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…